00:00
00:00
00:00
ValiRx - VAL301 update

Victoria D'Aquino, Research & Development Officer at ValiRx, the clinical stage biotechnology company, provides an update on VAL301. This is following the announcement that the Company’s clinical team has signed an agreement to work with Aptus Clinical Ltd, the UK based, clinical Contract Research Organisation, to effectuate a clinical development plan for VAL301 incorporating a Phase I/II study design concept in Endometriosis.

Victoria D'Aquino
Research and Development Officer

Company Events - VALIRX PLC